Abstract:Objectives: Peroxisome proliferator-activated receptor gamma coactivator 1α (PGC1α) controls mitochondrial biogenesis, but its role in cardiovascular diseases is unclear. The purpose of this study is to explore the effect of PGC1α on myocardial ischemia-reperfusion injury and the underlying mechanisms. Methods: The transverse coronary artery of SD rat was ligated for 30 minutes followed by 2 hours of reperfusion. Triphenyltetrazolium chloride (TTC) staining was performed to measure the area of myocardial infarction. Immunohistochemistry and Western blotting were used to detect the PGC1α expression in myocardium. The rat cardiomyocyte H9C2 was subjected to hypoxia/reoxygenation (H/R) with the knockdown of PGC1α or hypoxia- inducible factor 1α (HIF-1α), or with treatment of metformin. Western blotting was used to detect the expression of PGC1α, HIF-1α, p21, BAX, and caspase-3. CCK-8 was performed to detect cell viability, and flow cytometry was used to detect apoptosis and mitochondrial superoxide (mitoSOX) release. RT-qPCR was used to detect the mRNA expression of PGC1α and HIF-1α. Besides, chromatin immunoprecipitation (ChIP)-qPCR and luciferase reporter gene assay were applied to detect the transcriptional regulation effect of HIF-1α on PGC1α. Results: After I/R, the PGC1α expression was increased in infarcted myocardium. H/R induced H9C2 cell apoptosis (P<0.001). The release of mitoSOX (P<0.001) and protein expression of PGC1α, and apoptosis-related p21, BAX, and caspase-3 were increased. However, knockdown of PGC1α reduced apoptosis (P<0.01) and mitoSOX release (P<0.001), and decreased protein expression of apoptosis-related gene. HIF-1α is bound to the promoter region of PGC1α. Knockdown of HIF-1α inhibited the transcription and protein expression of PGC1α and further to reduce the apoptosis (all P<0.001) and mitoSOX release (P<0.01). While overexpression of PGC1α reversed the effects caused by HIF-1α knockdown (all P<0.001). Metformin effectively reduced H/R-induced apoptosis (P=0.013), mitoSOX release (P<0.001), HIF-1α, PGC1α and apoptosis-related protein expression, recovered the cell viability (P<0.001), and reduced myocardial infarction (P=0.003). Conclusions: After I/R, HIF-1α up-regulates the expression of PGC1α, leading to an increase in ROS production and aggravation of injury. Metformin can inhibit the accumulation of HIF-1α during hypoxia and effectively protect myocardium from ischemia/reperfusion injury.

Prostaglandin E1 Protects Cardiomyocytes Against Hypoxia-Reperfusion Induced Injury Via the Mir-21-5p/faslg Axis

Knock-down of Farnesyl Pyrophosphate Synthase Protects Heart-Derived H9c2 Cells Against Hypoxia/reoxygenation-Induced Injury.

Effect of Geranylgeranyl Pyrophosphate Synthase on Hypoxia/Reoxygenation-Induced Injury in Heart-Derived H9c2 Cells.

Prostaglandin E1 Attenuates Post-Cardiac Arrest Myocardial Dysfunction via Inhibiting Mitochondria-Mediated Cardiomyocyte Apoptosis

Prostaglandin E1 attenuates post‐cardiac arrest myocardial dysfunction through inhibition of mitochondria‐mediated cardiomyocyte apoptosis

Effects of prostagladin E1 on hypoxia/reoxygenation apoptosis in cultured neonatal rat cadiomyocytes

Hypoxia–reoxygenation‐induced Apoptosis in Cultured Neonatal Rat Cardiomyocyets and the Protective Effect of Prostaglandin E1

Protective effects of Prostaglandin E_1 in rat hepatic ischemia/reperfusion injury

Cardiac protection of prostacyclin secreted from endothelial progenitor cells against oxidative stress-induced apoptosis：verified by cardiac electrophysiological tests

Pretreatment with prostaglandin E1 attenuates myocardial injury caused by isoproterenol

Effects of PGC1 α on myocardial ischemia reperfusion injury and the underlying mechanisms

Plantamajoside protects H9c2 cells against hypoxia/reoxygenation-induced injury through regulating the akt/Nrf2/HO-1 and NF-kappa B signaling pathways

Protective Effects of Prostaglandin E1 Pretreatment on Myocardic Ultrastructure by Ischemia-reperfusion Injury in Rats

Plantamajoside protects H9c2 cells against hypoxia/reoxygenation-induced injury through regulating the akt/Nrf2/HO-1 and NF-κB signaling pathways

Notoginsenoside R1 protects hypoxia-reoxygenation deprivation-induced injury by upregulation of miR-132 in H9c2 cells

GLP-1 Agonist Protects Myocardial Hypoxia-Reoxygenation Injury Through PI3K/ Akt Signaling Pathway: an Experimental Study

Effects of PGC1α on Myocardial Ischemia Reperfusion Injury and the Underlying Mechanisms.

Glucagon-like peptide-1 attenuates endoplasmic reticulum stress–induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways

Protective effect of ginsenoside Rg1 on hypoxia/reoxygenation injury and its mechanism

Mir-181C-5p Exacerbates Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis Via Targeting PTPN4

The gut microbial metabolite phenylacetylglycine protects against cardiac injury caused by ischemia/reperfusion through activating β2AR